Kenneth A. Howard

8.7k total citations · 1 hit paper
108 papers, 6.8k citations indexed

About

Kenneth A. Howard is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Kenneth A. Howard has authored 108 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 22 papers in Radiology, Nuclear Medicine and Imaging and 20 papers in Biomedical Engineering. Recurrent topics in Kenneth A. Howard's work include RNA Interference and Gene Delivery (53 papers), Advanced biosensing and bioanalysis techniques (38 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Kenneth A. Howard is often cited by papers focused on RNA Interference and Gene Delivery (53 papers), Advanced biosensing and bioanalysis techniques (38 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Kenneth A. Howard collaborates with scholars based in Denmark, United Kingdom and United States. Kenneth A. Howard's co-authors include Jørgen Kjems, Flemming Besenbacher, Michael Lykke Hvam, Maja Thim Larsen, Matthias Kuhlmann, Morten Østergaard Andersen, Mingdong Dong, David Oupický, Ulrik L. Rahbek and Xiudong Liu and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nano Letters.

In The Last Decade

Kenneth A. Howard

106 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Albumin-based drug delivery: harnessing nature to cure disease

2016 537 citations Kenneth A. Howard et al. profile →

Peers

Countries citing papers authored by Kenneth A. Howard

Since Specialization

Citations

This map shows the geographic impact of Kenneth A. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth A. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth A. Howard more than expected).

Fields of papers citing papers by Kenneth A. Howard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth A. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth A. Howard. The network helps show where Kenneth A. Howard may publish in the future.

Co-authorship network of co-authors of Kenneth A. Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth A. Howard. A scholar is included among the top collaborators of Kenneth A. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth A. Howard. Kenneth A. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction 2025 ·Journal of Biological Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anaïs Jiménez-Reinoso, Marie B. Iversen, (unknown), Ryo Narita, Susana Frago, Kristine Raaby Jakobsen, Jan Terje Andersen, Søren E. Degn, Søren R. Paludan, Luis Álvarez‐Vallina, Kenneth A. Howard	0
2	ADAMTS5-specific gapmer release from an albumin biomolecular assembly and cartilage internalization triggered by ultrasound 2025 ·Drug Delivery ·(unknown), Gonçalo Barreto, (unknown), (unknown), Laura B. Creemers, Heikki J. Nieminen, Kenneth A. Howard	0
3	An Albumin-Holliday Junction Biomolecular Modular Design for Programmable Multifunctionality and Prolonged Circulation 2024 ·Bioconjugate Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yunpeng Cai, (unknown), (unknown), (unknown), Jesper S. Nielsen, Vijay Chudasama, James R. Baker, Kurt V. Gothelf, Jesper Wengel, Jørgen Kjems, Kenneth A. Howard	3
4	A Modular Albumin-Oligonucleotide Biomolecular Assembly for Delivery of Antisense Therapeutics 2024 ·Molecular Pharmaceutics ·(unknown), (unknown), Morten Foss, Laura B. Creemers, Kenneth A. Howard	3
5	Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design 2022 ·British Journal of Cancer ·(unknown), (unknown), Yonghui Zhang, (unknown), Paul Vinu Salachan, Michael Borre, Karina D. Sørensen, Kenneth A. Howard	6
6	An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension 2022 ·Acta Biomaterialia ·(unknown), Imke Rudnik‐Jansen, (unknown), (unknown), (unknown), Kader Thiam, Jørgen Kjems, Finn Skou Pedersen, Kenneth A. Howard	4
7	Functionalized Acyclic (l)‐Threoninol Nucleic Acid Four‐Way Junction with High Stability In Vitro and In Vivo 2022 ·Angewandte Chemie International Edition ·(unknown), Vipin Kumar, (unknown), (unknown), (unknown), (unknown), Imke Rudnik‐Jansen, Jesper S. Nielsen, Kenneth A. Howard, Jørgen Kjems, Kurt V. Gothelf	12
8	Albumin Biomolecular Drug Designs Stabilized through Improved Thiol Conjugation and a Modular Locked Nucleic Acid Functionalized Assembly 2022 ·Bioconjugate Chemistry ·(unknown), (unknown), (unknown), (unknown), Johan Palmfeldt, Vijay Chudasama, Jesper Wengel, Kurt V. Gothelf, James R. Baker, Kenneth A. Howard	7
9	Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity 2021 ·Communications Biology ·(unknown), (unknown), Simón Lykkemark, (unknown), Imke Rudnik‐Jansen, (unknown), Jan Terje Andersen, Luis Álvarez‐Vallina, Kenneth A. Howard	43
10	Per‐glycosylation of the Surface‐Accessible Lysines: One‐Pot Aqueous Route to Stabilized Proteins with Native Activity 2021 ·ChemBioChem ·Raoul Walther, (unknown), (unknown), (unknown), Jannik Nedergaard Pedersen, Azad Farzadfard, (unknown), Kenneth A. Howard, Daniel E. Otzen, Alexander N. Zelikin	1
11	Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4 2020 ·The Journal of Immunology ·Kristian Juul‐Madsen, Per Qvist, (unknown), Annette E. Langkilde, Bente Vestergaard, Kenneth A. Howard, (unknown), Søren R. Paludan, G.R. Andersen, Poul Henning Jensen, Daniel E. Otzen, Marina Romero‐Ramos, Thomas Vorup‐Jensen	26
12	Regulation of Gdf5 expression in joint remodelling, repair and osteoarthritis 2020 ·Scientific Reports ·Karolina Kania, (unknown), Anna H.K. Riemen, Hui Wang, Kenneth A. Howard, Thomas Aigner, Francesco Dell’Accio, Terence D. Capellini, Anke J. Roelofs, Cosimo De Bari	52
13	Roadmap on nanomedicine 2020 ·Nanotechnology ·Paolo Decuzzi, Dan Peer, Daniele Di Mascolo, Anna Lisa Palange, Purnima Naresh Manghnani, S. Moein Moghimi, Z. Shadi Farhangrazi, Kenneth A. Howard, Daniel Rosenblum, Tingxizi Liang, Zhaowei Chen, Zejun Wang, Jun‐Jie Zhu, Zhen Gu, Netanel Korin, Didier Letourneur, Cédric Chauvierre, Roy van der Meel, Fabian Kießling, Twan Lammers	21
14	Expression of growth and differentiation factor 5 during joint repair and osteoarthritis 2020 ·Osteoarthritis and Cartilage ·Karolina Kania, (unknown), Anna H.K. Riemen, Hailong Wang, Kenneth A. Howard, Thomas Aigner, Francesco Dell’Accio, Terence D. Capellini, Anke J. Roelofs, Cosimo De Bari	3
15	Hyaluronic Acid Molecular Weight-Dependent Modulation of Mucin Nanostructure for Potential Mucosal Therapeutic Applications 2017 ·Molecular Pharmaceutics ·(unknown), Morten Frendø Ebbesen, (unknown), Troels Thomsen, (unknown), Yunpeng Cai, Birgitte M. Malle, Kenneth A. Howard	39
16	Highly porous PEGylated Bi₂S₃nano-urchins as a versatile platform for in vivo triple-modal imaging, photothermal therapy and drug delivery 2016 ·Nanoscale ·Zhenglin Li, Ying Hu, Manli Chang, Kenneth A. Howard, (unknown), Ye Sun, Flemming Besenbacher, Miao Yu	93
17	Chitosan-Based Nanoparticles for Mucosal Delivery of RNAi Therapeutics 2014 ·Advances in genetics ·Alina Martirosyan, Morten T. Jarlstad Olesen, Kenneth A. Howard	28
18	The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice 2009 ·Molecular Therapy ·Shan Gao, Frederik Dagnæs‐Hansen, Ebbe Juel Bech Nielsen, Jesper Wengel, Flemming Besenbacher, Kenneth A. Howard, Jørgen Kjems	226
19	Delivery of RNA interference therapeutics using polycation-based nanoparticles 2009 ·Advanced Drug Delivery Reviews ·Kenneth A. Howard	164
20	Delivery of siRNA from lyophilized polymeric surfaces 2007 ·Biomaterials ·Morten Østergaard Andersen, Kenneth A. Howard, Søren R. Paludan, Flemming Besenbacher, Jørgen Kjems	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact